Le Kare 0.03mg/0.15mg Tablet
By Le Kare
Rx
21 Tablet in a Boxes

Composition
Ethinyl Estradiol(0.03mg) + Levonorgestrel(0.15mg)

Manufacturer - DKT India Ltd
67 A, 2nd Floor, Hem-dil Building, Linking Road, Opp. Lawrence English High School & Post Office, Santacruz West, Mumbai - 400054

Expires on or after
September, 2025

liver
There is limited information available on the use of Le Kare 0.03mg/0.15mg Tablet in patients with liver disease. It is strongly recommended to consult your doctor before starting this contraceptive.

kidney
Limited information is available regarding the use of Le Kare 0.03mg/0.15mg Tablet in patients with kidney disease. It is advised to consult your doctor before using this tablet to ensure your safety and well-being.

alcohol
When taking Le Kare 0.03mg/0.15mg Tablet, it is important to be cautious when consuming alcohol. Consult your doctor for guidance.

driving
When taking Le Kare 0.03mg/0.15mg Tablet, avoid driving if you notice any symptoms that can impact your focus and reaction time. It is uncertain if this medication affects driving abilities.

pregnancy
Le Kare 0.03mg/0.15mg Tablet is not safe to use during pregnancy, as it can harm the developing baby. Studies on pregnant women and animals have shown harmful effects. Seek doctor's advice.

breastfeeding
Le Kare 0.03mg/0.15mg Tablet may not be safe to use during breastfeeding. Limited data indicates it could pass into breastmilk and harm the baby. Consult your doctor before using it.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GYNAECOLOGICAL |
Action Class | - |
₹70
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024